Company profile

AINOSTICS company profile

The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2018-06-18

Headquarters

Headquarters
Oakhill, England, United Kingdom
Postal code
M3 3EB
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
12
Total equity funding
$2.6M
Last funding
Grant / $913.7K / 2024-12-01
Last equity funding
Undisclosed / $2.6M
Investors
7
Lead investors
1
Founders
1
Articles
2

Founders and investors

Founders

Hojjat Azadbakht

Lead investors

Innovate UK

Investors

Amazon Web ServicesEuropean CommissionInnovate UKNational Institute for Health and Care ResearchUK Research and Innovation

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.